Braucht Ihr Patient Glukokortikoide, sollten Sie unbedingt seine Blutzuckerwerte im Blick behalten. Verschlechtert sich seine Glukosestoffwechsellage, müssen Sie aber auf die Gabe der Glukokortikoide nicht verzichten. Vielmehr muss die Diabetestherapie angepasst werden. Wie Sie dabei im Einzelfall vorgehen sollten, erläutert der Autor des nachfolgenden Beitrags.
Literatur
Genolet P, Petite C, Petignat PA. Steroid-induced hyperglycemia, a common clinical problem in medicine without evidence-based guidelines. Rev Med Suisse. 2012;8(336):800–2, 804-5.
Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci. 2013;345(4):274–7
Lansang MC, Hustak LK. Glucocorticoid-induced diabetes and adrenal suppression: how to detect and manage them. Cleve Clin J Med. 2011;78(11):748–56.
Gulliford MC, Charlton J, latinovic R. Risk of diabetes associated with prescribed glucocorticoids in a large population. Diabetes Care. 2006;29:2728–2729.
Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236:619–632.
Blackburn D, Hux J, Mamdani M. Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med. 2002;17:717–720.
Clore JN and Thurby-hay L. Glucocorticoid-induced hyperglycemia. Endocrine Practice 2009; 15: 469–474.
Oyer DS, Shah A and Bettenhausen S. How to manage steroid diabetes in the patient with cancer. J Supportive Oncol 2006; 4: 479–483.
Colao A, Pivonello R, Spiezia S et al (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664–2672.
Seggelke SA, Gibbs J, Draznin B (2011) Pilot study of using neutral protamine hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes. J Hosp Med 6:175–176.
Raked D (1996) Postprandiale Hyperglykämie bei akuter Glukocorticoid-Verabreichung. Diabetes Stoffwechs 5:13–17.
Lobnig BM. Sekundäre Diabetesformen. Diabetologe 2011 • 7:425–438
Yuen KC, McDaniel PA, Riddle MC. Twenty-four-hour profiles of plasma glucose, insulin, C-peptide and free fatty acid in subjects with varying degrees of glucose tolerance following short-term, medium-dose prednisone (20 mg/day) treatment: evidence for differing effects on insulin secretion and action. Clin Endocrinol (Oxf). 2012;77(2):224–32.
Magee MH, Blum RA, Lates CD, Jusko WJ. Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race. J Clin Pharmacol. 2001;41(11):1180–94.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siegmund, T. Müssen die Glukokortikoide jetzt abgesetzt werden?. MMW - Fortschritte der Medizin 156 (Suppl 6), 90–93 (2014). https://doi.org/10.1007/s15006-014-3692-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15006-014-3692-4